乳腺癌基底细胞样亚型的免疫组织化学检测与预后分析
摘要
0引言乳腺癌是女性最常见的恶性肿瘤之一,不同亚型的乳腺癌的生物学行为、预后以及对治疗的反应各异。Perou等[1]首次提出乳腺癌的一种新亚型-基底细胞样亚型(basal-like breast carcinoma)。该亚型约占乳腺癌总数的16%[2]~37%[3]。
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2011年第6期712-713,共2页
Cancer Research on Prevention and Treatment
参考文献10
-
1Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797): 747- 752.
-
2van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome[J]. Am J Pathol, 2002, 161 (6): 1991-1996.
-
3Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets[J]. Proc Natl Acad Sci USA, 2003, 100 (14): 8418- 8423.
-
4Nielsen TO, Hsu FD, Jenson K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of inva- sive breast carcinoma[J]. Clin Cancer Res, 2004, 10 (16) : 5367-5374.
-
5Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast careinoma[J]. J Pathol,2004, 203(2): 661-671.
-
6Matos I, Dufloth R, Alvarenga M, et al. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas[J]. Virchows Arch,2005, 447 (4) : 688-694.
-
7Domagala W, Lasota J, Dukowicz A, et al. Vimentin expres- sion appears to be associated with poor prognosis in node-nega- tive ductal NOS breast carcinomas[J]. Am J Pathol, 1990, 137(6) : 1299-1304.
-
8Banerjee S, Reis-Filho J S, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J]. J Clin Pathol, 2006, 59(7): 729-735.
-
9Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classi- fication and prognosis based on gene expression profiles from a population-based study[J]. Proc Natl Acad Sci USA, 2003, 100(18) : 10393-10398.
-
10Sorlie T,Perou CM, Tibshirani R, et al. Gene expression pat- terns of breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Natl Acad Sci USA, 2001, 98 (19) : 10869-10874.
-
1金广超,臧益秀,李钧,陈连胜,田斌,王晓.乳腺癌患者外周血CK5/6/18阳性细胞的检测及其临床意义[J].中国现代普通外科进展,2007,10(3):254-256. 被引量:1
-
2张丙信,赵霞,贾喜花,张金库.凋亡相关基因p53和bax在基底细胞样乳腺癌中的表达及意义[J].现代肿瘤医学,2015,23(11):1533-1535. 被引量:1
-
3刘中正,韩涛,李恒宇,杨晓丹,刘兆喆,谢晓冬.三阴性乳腺癌组织CK5/6表达与血行微小转移关系的研究[J].解放军医药杂志,2017,29(4):5-8. 被引量:7
-
4许丽娟,刘彤,杨建杰,刘凤阁,崔莉,胡艳萍,刘辉,李新飞.三阴性乳腺癌与基底细胞样乳腺癌临床病理分析[J].实用癌症杂志,2010,25(1):62-64. 被引量:9
-
5曹华,郑涛,许瑞莲,陈亦欣,闫茂生.CK5/6、CK14、CK17、EGFR、BRCA1、BRCA2在三阴性乳腺癌中表达的研究[J].中国临床医生杂志,2014,42(8):32-35. 被引量:1
-
6王静,谷华伟,洪永贵.不同分子亚型的晚期乳腺癌化疗探析[J].中国医药指南,2013,11(35):428-429. 被引量:1
-
7赵晶,付丽,刘红,顾林,谷峰,郭晓静,范宇,郎荣刚.乳腺癌分子分型临床病理学特点及预后研究[J].中国肺癌杂志,2009,12(6):645-645. 被引量:4
-
8木扎帕尔·阿不都克热木,玉素甫·买买提,马斌林.联合应用表柔比星与多西他赛辅助化疗三阴乳腺癌的疗效分析[J].国际肿瘤学杂志,2014,41(7):556-557. 被引量:3
-
9史亚飞,韩晓菲,李磊,张仁亚,刘启龙.乳腺癌分子分型在新辅助化疗中的疗效预测[J].济宁医学院学报,2015,38(5):327-330. 被引量:1
-
10童钟,李鸿君,朱立新.不同分子亚型可手术乳腺癌患者个体化综合治疗的临床观察[J].中国普通外科杂志,2012,21(11):1353-1356. 被引量:10